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Aim: The aim of this study is to evaluate incidence of adverse cardiac events in patients with chest
pain with or without known existing coronary disease presenting normal electrocardiogram (ECG) and
initial troponin.
Methods: Prospective, nonrandomized study enrolled low-risk patients with normal ECG and troponin
on admission who underwent observation and/or stress testing by unstandardized clinical judgment.
Patients who experienced recurrent angina or positive ECGs or positive troponins during observation
or patients with positive stress testing were admitted; otherwise, they were discharged.
End Point: The end points are cardiac events at short- and long-term follow-up including
cardiovascular death, myocardial infarction, unstable angina, and revascularization.
Results: Of 5656 patients considered, 1732 with ischemic ECG were initially admitted and, therefore,
excluded from the analysis; 2860 with pleuritic chest pain and normal ECG were discharged; 1064
with visceral chest pain and normal ECG were enrolled. Patients with known coronary disease (45%)
were older and likely presented known vascular disease. Patients with known vascular disease, older
age, female sex, diabetes mellitus, and lower chest pain score were likely managed with observation.
In patients with known coronary disease as compared with patients without, overall cardiac events
account for 35% vs 14%, respectively (P b .001), as follows: in-hospital, 23% vs 10%, (P b .001); 1
month, 4% vs 2% (P = .133); and 9.9 ± 4.9 months, 8% vs 2%, respectively (P b .001).
Conclusions: One-third of patients with chest pain with known coronary disease, negative ECG, and
biomarkers were subsequently found to have adverse cardiac events. The value of this research for an
emergencymedicine audience could be extended to all clinicians and general practitioners beyond cardiologists.
© 2012 Published by Elsevier Inc.⁎ Corresponding author. Emergency Medicine Department, Careggi University Hospital and Department of Critical Care Medicine and Surgery, University
of Florence, Florence, Italy.
E-mail address: aaaconti@hotmail.com (A. Conti).
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Table 1 Clinical chest pain score
Score
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Chest pain is one of the most frequent complaints of
patients presenting to the emergency department (ED);
they represent approximately 10% of the population in
second-level EDs or reference centers [1,2]. Among these
patients, approximately one-third presented electrocardio-
graphic (ECG) changes suggestive of acute myocardial
ischemia; however, approximately one-half of patients with
acute myocardial infarction do not show any diagnostic
ECG changes at presentation [1-3]. Of note, up to 5% of
patients without diagnostic ECG changes sent home turn
out to be affected by acute myocardial infarction; mortality
rate among this population resulted 2 times higher than
patients identified and treated, with legal consequences [3].
Thus, immediate evaluation on presentation to the ED is
unreliable to rule out myocardial ischemia, so an updated
risk assessment by a 6-hour workup with serial ECGs and
serial troponins is needed eventually in patients presenting
visceral chest pain to separate patients at high risk for
cardiac event who need admission from those at low risk
who could be directly discharged. In addition, only
patients presenting hard clinical risk profile suspected of
myocardial ischemia, beyond first-level workup, could be
subjected to further instrumental evaluation [1,2,4-7].
Thus, diagnosis of acute coronary syndromes in patients
presenting to the ED with chest pain and nondiagnostic
ECG, considered at low risk for coronary events, is still a
challenge for physicians despite careful observation and
diagnostic tools. Large part of articles exists that have
discussed this issue in low-risk patients with no history of
ischemic heart disease. In those articles, patients have been
recognized as having a substantial percentage of coronary
disease [1,8-11]. Conversely, the incidence of actual risk
in patients presenting chest pain and nondiagnostic ECG
associated with known existing ischemic heart disease is
still unclear. Thus, aim of present study was to evaluate in
the real world how high could be the presence of
myocardial ischemia in patients with chest pain with or
without known existing coronary disease presenting
normal ECG and nondiagnostic first-line workup. The
value of this research for an emergency medicine audience
could be extended to all clinicians and general practi-
tioners beyond cardiologists.Location
Substernal, precordial +3
Left chest, neck, lower jaw, epigastrium +1
Apex −1
Radiation
Either arm, shoulder, back, neck, lower jaw +1
Character
Crushing, pressing, heaviness +3
Sticking, pleuritic, pinprick −1
Associated symptoms
Dyspnea, nausea, diaphoresis +22. Methods
The study enrolled patients with chest pain presenting to
the ED of the tertiary care teaching hospital in Florence,
Italy, with a catchment area serving a population of half
million. Facilities for triage of patients with suspected acute
coronary syndrome included an observation unit with
monitor equipped beds and dedicated personnel (resident,
faculty, and cardiologist on call). The observation unit islocated inside the ED in the same building of catheteriza-
tion laboratory, coronary care unit, cardio surgery ward,
and radiology and includes a 6-bed intensive unit plus a
22-bed unit. Coded diagnoses are entered into a electronic
medical chart, allowing easy selection of all patients with a
diagnosis of interest. Data were collected from August 1,
2008, to December 31, 2009. All patients gave their
consent for study participation. The study was conducted
according to good clinical practice and the Helsinki
Principles. The authors of this manuscript have certified
that they comply with the Principles of Ethical Publishing
in the International Journal of Cardiology.
2.1. Study population
Patients presenting chest pain as chief complaint were
considered for enrollment and initially evaluated with
physical examination including history with coronary risk
factors, ECG, and troponin I test [1,2]. Moreover, patients
with typical chest pain suspected of myocardial ischemia
were subjected to observation with serial ECGs and serial
troponin I test. All the patients underwent resting echocar-
diography [1,2,12,13]. Patients with abnormal ECG and
diagnosis of acute myocardial infarction or unstable angina
were admitted to the coronary care unit. Patients with
moderate to severe comorbidities with other chief complaints
and chest pain were admitted to the medical ward or
intermediate care unit. Patients with pleuritic chest pain were
subjected to a first-line workup lasting up to 6 hours
especially those with history of coronary artery disease or
multiple coronary risk factors who were subjected to
echocardiography [14-16]. Eventually, patients with nega-
tive ECGs and negative serum concentrations of troponin I
and at least patients with negative echocardiography were
considered at very low risk for coronary events and were
discharged home [4,5,7,12,17,18]. All the other patients with
visceral chest pain and nondiagnostic ECGs were enrolled in
the study [1,2]. Chest pain was characterized with a validated
chest pain score (Table 1) [19].
Tourists and inhabitants outside the catchment area of
Careggi University Hospital serving a population of half
3Management of patients with chest painmillion were not enrolled in the study and were not submitted
to follow-up.
2.2. Patients' management
Twelve-lead ECG and troponin I test were performed
on the admission and after 6 hours or as required by
clinical evolution (ie, recurrent chest pain). Definition of
acute coronary syndromes that has been applied was in
line with the European and American College of
Cardiology/American Heart Association Guidelines for
the their management. Patients were considered as having
normal, nondiagnostic ECG in the presence of normal ST-
segment and T-wave or at least ST-segment elevation or
depression less than 0.05 mV (0.5 mm) or asymmetrical
T-wave inversion less than 0.2 mV (2 mm) or Q waves
less than 0.03 seconds. Such mild changes should be
observed in less than 2 contiguous leads. ST elevation or
depression between 0.05 and 0.1 mV (0.5-1 mm) or
asymmetrical T-wave inversion between 0.2 and 0.25 mV
(2-2.5 mm) were considered abnormal nondiagnostic ECG
alterations; also, complete bundle-branch block and paced
rhythm were considered abnormal nondiagnostic ECG
alterations [12,17,19].
The value of troponin was considered positive if above
the 99° percentile of a control group in at least 1 set
eventually during the first 24 hours after onset of
symptoms [1,13]. All the patients received resting
echocardiography [1,2,12,13]. Patients showing ischemic
ECG changes with or without troponin elevation, with or
without cardiac wall motion abnormalities at the echocar-
diography during observation, were considered at high risk
of cardiac events [12,17,19], and they were admitted and
considered for coronary angiography. Patients with
negative troponins, negative ECGs, normal echocardiog-
raphy during observation, and pleuritic chest pain were
considered at very low risk for coronary artery disease and
were discharged with planned office follow-up [1,2]. All
the other patients with visceral chest pain were considered
for clinical observation or submitted to stress testing
without standardized approach. Patients with clinical
observation diagnostic of coronary artery disease or
positive stress testing were considered at high risk for
coronary events, and they were admitted and considered
for catheterization laboratory unit. This subset of patients
constituted in-hospital cardiac event group [19-22].
Eventually, patients with negative clinical observation or
negative stress testing were considered at very low risk
and were discharged with office follow-up [1].
2.3. Stress testing
Early symptoms limited graded exercise ECG was
performed after the first 6 hours of observation and no
further than 24 hours from presentation. Diagnosis ofmyocardial ischemia was considered for the development
of ST depression of at least 1 mm measured at 60
milliseconds from J point. In patients unable to exercise
ECG, pharmacologic stress echocardiography was per-
formed after drug washout. Dobutamine was administered
in continuous infusion at initial doses of 5 μg/kg per minute
with increases every 3 minutes at 10, 20, and 30 μg/kg per
minute reaching the maximum dose of 40 μg/kg per minute
[19,23]. If the target heart rate was not reached, atropine was
administered in intravenous at doses of 0.25 mg/min up to
the maximum dose of 1 mg. Positive stress echocardiography
was defined by the new detection or increasing onset of
preexisting kinetics alterations or by the onset of angina and/
or ECG changes. Eventually, pharmacologic stress myocar-
dial perfusion imaging (single photon emission computed
tomography) was performed after drug washout [22,24].
Adenosine was given intravenous at the dose of 140 μg/min
per kilogram for a period of 6 minutes, and radioactive tracer
(25 MBq of technetium Tc 99m sestamibi myocardial
perfusion tracer) was injected at the third minute. After 20
minutes from the injection of radioactive tracer, images were
acquired using a double-head gamma chamber with 90°
between the 2 heads, equipped with a high-resolution
collimator. Gated single photon emission computed tomo-
graphic images were acquired at rest and after stress with the
patient in supine position (64 angular views at 3° intervals,
each one lasting 30 seconds through elliptical orbit of 180°
and a matrix of 64 × 64 × 16 bytes, zoom 1.46; at each view
the cardiac cycle was split into 8 intervals).
2.4. End point
End point was the evidence of coronary eventswithin short-
and long-term follow-up including cardiovascular death,
myocardial infarction, unstable angina, and revascularization.
2.5. Follow-up
Follow-up was performed reviewing the ED access
archives or by telephone after 1, 6, and 12 months in
patients discharged with negative clinical evaluation or
negative stress testing. Positive events of suspected coronary
events were analyzed and confirmed after clinical charts,
ECGs, and laboratory tests review. Tourists and inhabitants
outside the catchment area of Careggi University Hospital
serving a population of half million were not enrolled in the
study and were not submitted to follow-up.
2.6. Statistics analysis
Continuous variables were reported as mean ± SD.
Frequencies are shown as percentages and absolute values.
Continuous variables were compared through 1-way analysis
of variance and t test, whereas percentages were compared
with χ2 or Fisher exact test when expected frequencies were
4 A. Conti et al.less than 5%. A 2-tail P value less than .05 was considered
statistically significant. Statistical analysis were performed
using SPSS Package, version 17 (SPSS, Inc, Chicago, IL).3. Results
A total of 5656 patients presenting to the ED with chest
pain as chief complaint were considered; 1732 (31%) were
admitted with the evidence of ischemic ECG and acute
coronary syndrome or another concomitant disease (813 with
moderate to severe comorbidities were submitted to the
wards, and 919 with acute coronary syndrome were admitted5 656,
presenting chest pain a
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Table 2 Baseline clinical characteristics of patients enrolled in
the study (n = 1064)
Known
coronary
disease
(n = 477, 45%)
Unknown
coronary
disease
(n = 587, 55%)
P
Mean age (y, SD) 72, 12 62, 14 b.001
Male sex 283 (59.3%) 316 (53.8%) .07
Diabetes mellitus 75 (15.7%) 69 (11.8%) .06
Hypertension 240 (50.3%) 288 (49.1%) .68
Hypercholesterolemia 99 (20.8%) 119 (20.3%) .84
Active smoker 40 (8.4%) 126 (21.5%) b.001
Obesity 21 (4.4%) 22 (3.7%) .59
Familiarity 12 (2.5%) 82 (14%) b.001
Abdominal aneurism
of aorta
21 (4.4%) 14 (2.4%) .07
Peripheral arterial
vascular disease
35 (7.3%) 13 (2.2%) b.001
Stroke 29 (6.1%) 16 (2.7%) .004
Carotid stenoses 23 (4.8%) 15 (2.6%) .047
Chest pain score 5.3 1.9 5.5 2.0 .31
1 064 l i k ti t, ow-r s  pa en s
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observed
477 (45%) with 
known coronary disease
289 (61%) managed 188 (39%) managed
without stress testing with stress testing
Admitted if: Admitted if: + testing
clinical deterioration
(+ ECG + Troponin
+ testing - testing
, ,
+ unstable angina) or
39(21%) 149(79%)+ comorbidities)
108(23%)
In hospital coronary events-
18 (3%)
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ig. 2 Flow diagram of patients with known coronary disease
nrolled in the study (n = 477). End point: cardiovascular death,
yocardial infarction, unstable angina, and revascularization
uring in-hospital stay, at short-term (1 month) and long-term
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5Management of patients with chest paincoronary disease, and the remaining 587 patients (55%)
had not (Figs. 2 and 3). Patients with known coronary
disease were older and presented more known vascular
disease. Moreover, because of the nonrandomized criteria
of enrollment, patients with older age, female sex, diabetes
mellitus, known vascular disease, and lower chest pain
score were likely managed with observation (Table 3).
Overall, 556 patients (52%) were managed with observa-
tion, and 508 patients (48%) were managed with stress
testing, of whom 440 with exercise ECG and 68, unable to
perform exercise, underwent stress echocardiography (n =
65) or myocardial perfusion imaging (n = 3). In patients
with known coronary disease as compared with patients
without, overall cardiac events account for 35% vs 14%,
respectively (P b .001) as follows: in-hospital, 23% vs
10%, respectively (P b .001); 1 month 4% vs 2%,
respectively (P = .133); and 9.9 ± 4.9 months 8% vs 2%,
respectively (P b .001) (Table 4). In the group with known
coronary disease, at 1-month follow-up, of 18 patients with
coronary events, 10 patients were recognized as having
unstable angina subjected to mechanical revascularization,
and 8 patients angina subjected to conservative treatment.
At 9.9 ± 4.9 months of follow-up, of 39 patients with
coronary events, 2 patients were recognized as having
unstable angina or myocardial infarction subjected to
mechanical revascularization; the remaining 11 patients
with myocardial infarction and 36 patients with angina
were subjected to conservative treatment. Conversely, in
the group without known coronary disease, at 1-month
follow-up, of 13 patients with coronary events, 7 patients
were recognized as having unstable angina or myocardial
infarction subjected to mechanical revascularization; the
remaining 1 patient with myocardial infarction and 5F
e
m
d
(9patients with angina were subjected to conservative
treatment. At 9.9 ± 4.9 months of follow-up, of 13
patients with coronary events, 1 patient was recognized as
having unstable angina subjected to mechanical revascu-
larization; 12 patients with angina were subjected to
conservative treatment. Twenty-two patients were lost at
follow-up (2% of enrolled patients), 10 patients with
known existing coronary disease and 12 patients without.4. Discussion
Diagnosis of myocardial ischemia in patients presenting
chest pain and normal ECG, considered at low risk for
cardiac events, represented a challenge for physicians in last
decades, despite well-planned strategies including diagnostic
algorithm, careful observation, and diagnostic tools
[1,2,10,11]. Efforts have been planned in improving
Table 3 Baseline clinical characteristics of patients enrolled
in the study and subjected to stress testing or tailored
observation strategy (n = 1064)
Stress testing
(n = 508)
Observation
(n = 556)
P
Mean age (y, SD) 64.3, 12.2 68.1, 15.4 b.0001
Sex (male) 310 (61.0%) 289 (52.0%) .003
Diabetes mellitus 50 (9.8%) 94 (16.9%) .0008
Hypertension 250 (49.2%) 278 (50.0%) .80
Hypercholesterolemia 112 (22.0%) 106 (19.1%) .23
Smoker 86 (16.9%) 80 (14.4%) .25
Obesity 25 (4.9%) 18 (3.2%) .16
Familiarity 52 (10.2%) 42 (7.6%) .12
Known coronary
artery disease
188 (37.0%) 289 (52.0%) b.0001
Abdominal aneurism
of aorta
18 (3.5%) 17 (3.1%) .66
Peripheral arterial
vascular disease
15 (3.0%) 33 (5.9%) .02
Stroke 19 (3.7%) 26 (4.7%) .45
Carotid stenoses 14 (2.8%) 24 (4.3%) .17
Chest pain score 6.5 2.6 4.9 1.6 b.0001
Table 4 End point in patients with known or unknown
coronary artery disease
Known
CAD
P Unknown
CAD
In-hospital cardiac events 108 (22.4%) b.0001 59 (10.0%)
Short-term cardiac events 18 (3.8%) .133 13 (2.2%)
Long-term cardiac events 39 (8.2%) b.0001 13 (2.2%)
End point: cardiovascular death, myocardial infarction, unstable angina,
and revascularization during in-hospital stay, at short-term (1 month)
and long-term (9.9 ± 4.9 months) follow-up. CAD indicates coronary
artery disease.
1 064 l i k ti t, ow-r s  pa en s
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, ,
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Fig. 3 Flow diagram of patients without known coronary disease
enrolled in the study (n = 587). End point: cardiovascular death,
myocardial infarction, unstable angina, and revascularization
during in-hospital stay, at short-term (1 month) and long-term
(9.9 ± 4.9 months) follow-up.
6 A. Conti et al.recognition of coronary disease and ruling out myocardial
ischemia. Indeed, in recent years, low-risk patients without
known existing coronary disease have been recognized as
having a substantial percentage of coronary disease up to
15% to 20% [1,2,8-11]. As a consequence of efforts, patients
inadvertently discharged home reduced to less than 2%
[3,20]. This issue have been discussed in a large part of
articles concerning low-risk patients with any history of
ischemic heart disease [2,8-10]. However, incidence of
myocardial ischemia in patients with chest pain with known
existing coronary disease is still unclear. In these patients,
present study shows that overall cardiac events were
significantly higher in patients with known coronary disease
as compared with patients without (35% vs 14%, respec-
tively; P b .001) and at long term (8% vs 2%, respectively;
P b .001; Table 4). Interestingly, patients with known
coronary disease showed overall cardiac events 2-fold higherthan patients without, and surprisingly, cardiac events were
up to 4-fold higher at long term. As a consequence,
noninvasive management of patients with known coronary
disease could be unreliable in the real world, and physicians
in the ED are likely to miss acute myocardial ischemia,
particularly when patients had history of coronary disease.
The value of this research for an emergency medicine
audience could be extended to all clinicians and general
practitioners beyond cardiologists.
Previous studies of patients with acute chest pain and
absence of ECG signs of myocardial ischemia reported only
4% of patients with a history of coronary artery disease, and
2% of patients without such a history will develop an acute
myocardial infarction [1,2]. Observation beyond first-line
evaluation associated with serial ECGs and serial troponins
demonstrated high sensitivity in recognition non–ST-
elevation myocardial infarction in this subset of patients
[1,2,4,5]. Moreover, exercise ECG and stress imaging have
7Management of patients with chest painbeen highlighted by several authors as first screening tool in
diagnosing myocardial ischemia [2,17,21]. This global
management allows the physicians to give the patient safe
and effective evaluation that can rule out acute myocardial
infarction or identify myocardial ischemia. Eventually,
dedicated scoring systems including characterization of
chest pain and associated risk factors for arteriosclerosis
can guide the choice of appropriate diagnostic tool
optimizing risk stratification [8,9,19,25,26], but none of
them considered differences between patients with or
without history of coronary disease. Awareness of positive
history of coronary disease as strong risk factor of recurrent
acute coronary syndrome in patients with chest pain
nonetheless presenting normal ECG could lead to incorpo-
rate it into a novel diagnostic strategy and eventually could
update prognostic stratification.4.1. Strength and limitations of the study
Present study analyzed a large consecutive population in
the real world of a third-level ED and could represent a
pilot study in the emergency setting. In-hospital screening
succeed in separating a very large part of patients at high
risk for cardiac event who needed admission from those at
relatively low risk who could be discharged or submitted
to further evaluation. The study attempts to answer a
question, which is important for clinicians and academi-
cians alike. Overall results suggest one-third patients with
known coronary disease presenting nondiagnostic ECG
eventually developed cardiac events. The reported in-
cidences of adverse outcomes are relatively high compared
with the literature, but data could be due to the fact that no
patient was admitted directly to cardiology ward or
coronary care unit. However, chest pain evaluation
methodology could explain this discrepancy. Indeed, data
could have clinician bias in the nonstructured, nonrando-
mized methodologies used to manage patients. It does not
pose a necessarily novel question, nor does it represent
cutting edge decision making.
We are aware with data of literature showing that up to
5% to 15% of patients with acute coronary syndrome could
have pleuritic pain, but in our series, patients with pleuritic
pain discharged received 6-hour observation with negative
serial ECGs and serial troponins. The evaluation of outcome
based on dichotomy (normal/abnormal tests) may be a
limitation of any screening workup in patients with chest
pain. Results of present study could not be extended to
general population because patients with moderate to severe
comorbidities and chest pain were admitted to the medical
ward or intermediate care unit and were excluded from the
study. However, further studies are needed to establish
standardized criteria to guide the use of invasive or
noninvasive diagnostic strategy in these patients. Moreover,
our results need validation in other centers or need to be
confirmed in a properly designed study.4.2. Conclusions
Risk stratification with observation and stress testing is
safe and effective in patients without existing coronary
disease presenting chest pain and nondiagnostic first-line
workup. Conversely, one third of patients with chest pain
with known existing coronary disease and nondiagnostic
ECG and biomarkers eventually were recognized as having
coronary events. The value of this research for an emergency
medicine audience could be extended to all clinicians and
general practitioners beyond cardiologists.References
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